Neurological injury remains an important cause of morbidity and mortality in patients with ECPR. At present, the results of three prospective randomized controlled studies on ECPR are inconsistent, and it is inconclusive whether ECPR can improve the neurological outcomes of patients with refractory cardiac arrest. Several study found that extracorporeal membrane oxygenation nonsurvivors can lead toacute brain injury.Further research with a systematic neurologic monitoring is necessary to define the timing of acute brain injury in patients with extracorporeal membrane oxygenation.Moreover, brain injury that occurs during extracorporeal membrane oxygenation therapy is not easy to detect in time because of the use of analgesics, sedatives, and muscle relaxants. Surprisingly, little attention has been paid to the role of cerebral perfusion and oxygenation. Moreover,the features of cerebrovascular pathophysiology and optimal management strategies are still vague. Therefore multimodal neuromonitoring may be a valuable tool for detecting brain injury in patients with extracorporeal membrane oxygenation and providing early intervention guidance. The aim of this study is to test whether multimodal neuromonitoring will improve 30-day survival with a favorable neurologic outcome in ECPR patients with a refractory OHCA.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
654
ECMO flow, IABP , ventilator support parameters, temperature management level and time
Qilu Hospital
Jinan, Shandong, China
30-day survival rate with favorable neurological status
Cerebral Performance Category (CPC) score will be performed to evaluate the neurological status. A CPC score of 1 or 2 indicates a favorable neurological status.
Time frame: 30 days
Survival with favorable neurological status at 3, 6 months
Does multimodal neurological monitoring Strategy improve the neurological outcome at 3 months, 6 months. A Cerebral Performance Category (CPC) score of 1 or 2 indicates a favorable neurological status.
Time frame: 3 months, 6 months
Time to return of circulation
What is the time to return of circulation
Time frame: Within 1 year
Duration of mechanical ventilation
Is there a difference in the duration of mechanical ventilation between treatment groups
Time frame: 1 year
Length of stay at the ICU
Is there a difference in length of stay at the ICU between the treatment groups
Time frame: 1 year
Length of stay at the hospital
Is there a difference in length of stay at the hospital between the treatment groups
Time frame: 1 year
Duration of hypothermia
Is there a difference in duration of hypothermia between the treatment groups
Time frame: 1 year
Difference in NSE, S100 B level between treatment groups
Is there a difference in nerve damage Markers such as (1) NSE, (2) S100B at ROSC 24h, 48h, 72h between the treatment groups
Time frame: 3 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.